Description
Mazdutide is a dual agonist at GLP-1 and glucagon receptors, combining the insulinotropic and satiety-promoting effects of GLP-1 receptor activation with the energy expenditure and hepatic lipid-clearing effects of glucagon receptor engagement. Research has explored its utility in metabolic disease models, non-alcoholic fatty liver disease (NAFLD) research, and energy homeostasis studies.
Independently tested to 99%+ purity via HPLC and MS/MS. COA provided.
For research use only. Not for human or veterinary consumption.




